Orthobiologics Market Size

Orthobiologics Market size was valued at USD 8.46 billion in 2024 and is expected to exceed USD 17.04 billion by the end of 2037, expanding at over 5.7% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of orthobiologics is evaluated at USD 8.84 billion. The growth of the market can primarily be accounted to the rising cases of bone diseases across the globe. Based on the report provided by the National Library of Medicine (NLM), it was observed that around 1.5 million people suffer from fractures owing to some sort of bone disease every year.

Global orthobiologics market trends such as, the growing prevalence of low immunity and calcium deficiency owing to changing lifestyles and skyrocketing spending on medical technology are projected to influence the growth of the market positively over the forecast period. As of 2019, the total revenue generated by medical technology was anticipated to be nearly USD 450 billion while the R&D spending on this technology was estimated to be around USD 30 billion in the same year. Orthobiologics is an injectable therapy that utilizes biological substances to heal musculoskeletal injuries rapidly. The substances used in the therapy are made from the materials naturally produced by the body. Therefore, all these factors are anticipated to propel the growth of the market over the forecast period.